Good Find Jim...SRL would love to expand in the USA you understand..JA ....Radient is alive and well ..
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer July 07, 2014
New York, NY, July 7, 2014 - Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, today announced the appointment of Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer (COO). In this role, Dr. Mulpuri will be responsible for leading and managing all aspects of the company's operations, including integration of the scientific and business functions, as well as quality and regulatory oversight to support the launch of Provista's pipeline of products.
Dr. Mulpuri has proven credentials in the setup and management of global operations, translational research, informatics, and bringing molecular diagnostics to clinical practice. Most recently, he served as Vice President of Laboratory Operations for AssureRx Health, Inc., a personalized medicine company helping clinicians determine which behavioral medications work best for their patients. At AssureRx Health, he oversaw the establishment and management of multi-site clinical laboratories for the commercial testing of the company's diagnostic products.
"The appointment of Rao Mulpuri as COO underscores our commitment to hire highly experienced executives and create a world-class management team," said David E. Reese, PhD., Chief Executive Officer. "He combines an impressive track record in developing and commercializing complex diagnostics with a firm understanding of the operational leadership we need in getting our diagnostics to market as quickly as possible."
Dr. Mulpuri's experience also includes serving in various senior leadership positions for such organizations as the Catholic Health Initiatives Center for Translational Research, Beckman Coulter Genomics, and Cogenics Inc. He also founded MDxStrategy, a management and operational consulting firm that provides services to biobanks and genomic testing laboratories.
"This is a seminal period of growth for both Provista and molecular diagnostics. I can think of few challenges in medicine today that are more important than earlier detection and enhanced monitoring of cancer," Dr. Mulpuri commented. "I am very excited by Provista's product pipeline and look forward to bringing my expertise to help Provista become a preeminent diagnostic organization focused on women's health." Dr. Mulpuri will be based in Provista's Scottsdale office.
Dr. Mulpuri holds more than 14 patents, and has published numerous papers in peer-reviewed journals. He holds a PhD in physiology and biochemistry from Vikram University in India and an MBA with honors from Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.
News 
Market Data 
Discover 
AI
